Wegovy(R) (semaglutide injection) Receives Conditional Marketing Authorization from Health Canada as the First and Only Treatment for Adults with Non-Cirrhotic MASH, a Serious ...

The MarketWatch News Department was not involved in the creation of this content.-- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment ...
Everyday Health on MSN

What to expect when using a GLP-1 for MASH

Learn more about what to expect if you’ve been prescribed this weight loss medication to help treat this chronic liver condition.
Everyday Health on MSN

Using GLP-1s for MASH: Dos and don’ts

If you have MASH, GLP-1 medications may help treat the condition. Set yourself up for success with expert advice on diet, exercise, dose scheduling, and more.
Healthline

6 Effects of MASH on the Body

Metabolic dysfunction-associated steatohepatitis (MASH) starts in your liver, but it can have body-wide effects. These effects increase your risk of conditions like heart disease, chronic kidney ...

Wegovy® (semaglutide injection) Receives Conditional Marketing Authorization from Health Canada as the First and Only Treatment for Adults with Non-Cirrhotic MASH…

Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...